1.Sanofi and Regeneron Report Results of REGN3500 in P-II Study for Asthma

Published: Jun 21, 2019 | Tags: Sanofi, Regeneron, Report, Results, REGN3500, P-II, Study, Asthma

2.Bayer Initiates P-III Study of Aflibercept for the Prevention of Blindness in Premature Infants with Retinopathy of Prematurity

Published: Jun 21, 2019 | Tags: Bayer, Initiates, P-III, Study, Aflibercept, Prevention, Blindness, Premature Infants, Retinopathy of Prematurity

3. Valneva Terminates its Agreement with GSK for Regaining Control of Research and Development Assets

Published: Jun 20, 2019 | Tags: Valneva, Terminates, 2007, Agreement, GSK, Regain Control, Assets

4. IBRI Signs a License Agreement with Eli Lilly to Access its Fab Phage Display Library

Published: Jun 20, 2019 | Tags: IBRI, Signs, License Agreement, Eli Lilly, Access, Fab Phage Display Library

5. Novo Nordisk's Esperoct (turoctocog alfa pegol, N8-GP) Receives European Commission Approval for the Treatment of Hemophilia A

Published: Jun 20, 2019 | Tags: Novo Nordisk, Esperoct, turoctocog alfa pegol, N8-GP, Receives, European Commission, Approval, Treatment, Hemophilia A

6.Alexion's Ultomiris (ravulizumab) Receives MHLW's Marketing Authorization to Treat Paroxysmal Nocturnal Hemoglobinuria in Adults

Published: Jun 18, 2019 | Tags: Alexion, Ultomiris, ravulizumab, Receives, MHLW, Marketing Authorization, Paroxysmal Nocturnal Hemoglobinuria, Adults

7. Resolution Bioscience Collaborates with Janssen to Develop Cell-Free DNA CDx for Niraparib to Treat Prostate Cancer

Published: Jun 19, 2019 | Tags:Resolution Bioscience, Collaborates, Janssen, Development, Cell-Free, DNA, CDx, Prostate Cancer

8. Alexa to Detect Cardiac Arrest with AI-Enabled Tool for Smart Speakers and Smartphones

Published: Jun 19, 2019 | Tags: Alexa, Detect, Cardiac Arrest, AI- Enabled Tool, Smart Speakers, Smartphones

9. Amgen Signs a Research Agreement with the University of Washington's IPD for the Development of Protein-Based Therapies

Published: Jun 19, 2019 | Tags: Amgen, Signs, Research Agreement, University of Washington, IPD, Development, Protein-Based Therapies

10.Gilead Signs an Agreement with Nurix to Develop and Commercialize Protein Degradation Therapies for Cancer and Other Disease

Published: Jun 19, 2019 | Tags: Gilead, Signs, Agreement, Nurix, Develop, Commercialize, Protein Degradation Therapies, Cancer, Disease

11. Sanofi Signs an Agreement with Google to Develop Virtual Innovation Lab for Transforming Healthcare Services

Published: June 18, 2019 | Tags: Sanofi, Signs, Agreement, Google, Develop, Virtual, Innovation Lab, Transforming, Healthcare, Services

12. Bristol-Myers Squibb to Sell its Manufacturing Facility to Catalent in Anagni, Italy

Published: June 19, 2019 | Tags: Catalent, Buy, Manufacturing Facility, Bristol-Myers Squibb, Anagni, Italy

13. Roche's Hemlibra (emicizumab injection) Receives Health Canada Approval for Patients with Hemophilia A Without Factor VIII Inhibitors

Published: June 18, 2019 | Tags: Roche, Hemlibra, emicizumab injection, Receives, Health Canada, Approval, Patients, Hemophilia A Without Factor VIII Inhibitors

14.AstraZeneca's Breztri Aerosphere (PT010) and Bevespi Aerosphere Receive MHLW's Approval for Chronic Obstructive Pulmonary Disease in Japan

Published: June 19, 2019 | Tags: AstraZeneca, Breztri Aerosphere, PT010, Bevespi Aerosphere, Receive, MHLW, Approval, Chronic Obstructive Pulmonary Disease

15. Ironwood and Allergan Report Positive Results of Inzess (linaclotide) in P-IIIb Trial for Patients with Irritable Bowel Syndrome with Constipation

Published: June 19, 2019 | Tags: Ironwood, Allergan, Report, Positive, Results, Inzess, linaclotide, P-IIIb, Trial, Patients, Irritable Bowel Syndrome with Constipation, IBS-C           

16. Merck's Keytruda (pembrolizumab) Receives FDA's Accelerated Approval as a Monotherapy for Metastatic Small Cell Lung Cancer

Published: June 19, 2019 | Tags: Merck, Keytruda, pembrolizumab, Receives, FDA, Approval, Monotherapy, Metastatic, Small Cell Lung Cancer

17. Abbott Launches Afinion HbA1c Dx (Rapid Point-Of-Care Test) to Aid the Diagnosis of Diabetes

Published: June 17, 2019 | Tags: Abbott, Launches, Afinion HbA1c Dx, Rapid Point-Of-Care, Test, Aid, Diagnosis, Diabetes

18. AstraZeneca and MSD's Lynparza (olaparib) Receive European Commission's Approval as 1L Maintenance Treatment for BRCA-Mutated Advanced Ovarian Cancer

Published: June 18, 2019 | Tags: AstraZeneca, MSD, Lynparza, olaparib, Receive, European Commission, Approval, 1L, Maintenance Treatment, BRCA-Mutated, Advanced, Ovarian Cancer

19. Roche's Rozlytrek (entrectinib) Receives MHLW's Approval for NTRK Fusion-Positive Advanced Recurrent Solid Tumors in Adult and Pediatric Patients in Japan

Published: June 18, 2019 | Tags: Roche, Rozlytrek, entrectinib, Receives, MHLW, Approval, NTRK Fusion-Positive, Advanced, Recurrent, Solid Tumors, Adult, Pediatric, Patients

20. BeiGene Terminates its Worldwide Development and Commercialization Agreement with Celgene for Tislelizumab

Published: June 17, 2019 | Tags: BeiGene, Terminates, Worldwide, Development, Commercialization, Agreement, Celgene, Tislelizumab

21. Novo Nordisk's Victoza (liraglutide) Receives FDA's Approval for Type 2 Diabetes in Children and Adolescents

Published: June 17, 2019 | Tags: Novo Nordisk, Victoza, liraglutide, Receives, FDA, Approval, Type 2, Diabetes, Children, Adolescents

22.Immunophotonics Signs a Research Agreement with Clinical Laserthermia Clinical Laserthermia Systems for Cancer Patients with Solid Tumors

Published: June 14, 2019 | Tags: Immunophotonics, Signs, Research, Agreement, Clinical Laserthermia Systems, Cancer Patients, Solid Tumors

23. AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ASCEND Study for R/R Chronic Lymphocytic Leukemia #EHA2019

Published: June 17, 2019 | Tags: AstraZeneca, Reports, Results, Calquence, acalabrutinib, P-III, ASCEND, Study, R/R, Chronic Lymphocytic leukaemia, #EHA2019

24. Pfizer to Acquire Array Biopharma for ~$11.4B

Published: June 17, 2019 | Tags: Pfizer, Acquire, Array Biopharma, ~$11.4B

25. Janssen Reports Results of Tremfya (guselkumab) in Two P-III DISCOVER Studies for Psoriatic Arthritis

Published: June 14, 2019 | Tags: Janssens, Reports, Results, Tremfya, guselkumab, P-III, Two, DISCOVER, Studies, Psoriatic Arthritis